OBJECTIVE: The purpose of this study was to determine if there is any difference between AM and PM POPQ exam results. STUDY DESIGN: Prospective, IRB approved study of women presenting with pelvic organ prolapse symptoms. Initial POPQ exams were performed in the morning or afternoon; a second exam was performed within 4 weeks at the opposite time of day. Statistical analysis included Wilcoxon signed rank test, paired t test, Spearman correlation, and Stuart-Maxwell test. RESULTS: The study consisted of 32 subjects. Mean age was 58.8 years, mean BMI 28.6, median parity 2.0, 75% white, 22% black, and 3% Hispanic. The POPQ exam stages were 47% stage II, 50% stage III, and 3.0% stage IV. There was no significant difference for the 9 POPQ exam measures between morning and afternoon exams. There was good agreement between AM and PM POPQ ordinal stages (Stewart Maxwell P = 1.0, kappa 0.76). CONCLUSION: There is no difference between AM and PM POPQ exam results.
OBJECTIVE: The purpose of this study was to determine if there is any difference between AM and PM POPQ exam results. STUDY DESIGN: Prospective, IRB approved study of women presenting with pelvic organ prolapse symptoms. Initial POPQ exams were performed in the morning or afternoon; a second exam was performed within 4 weeks at the opposite time of day. Statistical analysis included Wilcoxon signed rank test, paired t test, Spearman correlation, and Stuart-Maxwell test. RESULTS: The study consisted of 32 subjects. Mean age was 58.8 years, mean BMI 28.6, median parity 2.0, 75% white, 22% black, and 3% Hispanic. The POPQ exam stages were 47% stage II, 50% stage III, and 3.0% stage IV. There was no significant difference for the 9 POPQ exam measures between morning and afternoon exams. There was good agreement between AM and PM POPQ ordinal stages (Stewart Maxwell P = 1.0, kappa 0.76). CONCLUSION: There is no difference between AM and PM POPQ exam results.
Authors: Deborah R Karp; Thais V Peterson; Marjorie Jean-Michel; Roger Lefevre; G Willy Davila; Vivian C Aguilar Journal: Int Urogynecol J Date: 2010-05-04 Impact factor: 2.894